MetaCap

Drugs Made In America Acquisition II (DMII) vs EQV Ventures Acquisition II (EVAC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Drugs Made In America Acquisition II is the larger company by market cap ($649.1 million vs $602.6 million), about 1.1 times the size. On valuation, Drugs Made In America Acquisition II trades at a lower trailing P/E (34.0x vs 34.4x for EQV Ventures Acquisition II).

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

DMII versus EVAC key metrics
MetricDMIIEVAC
Share price$10.19$10.31
Market cap$649.10M$602.60M
1-day change+0.05%-0.10%
P/E ratio (TTM)33.9734.37
EPS (TTM)$0.30$0.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.33$10.33
52-week low$9.86$9.90
Distance from 52-week high-1.36%-0.19%
Average volume53.22K98.08K
Shares outstanding63.70M46.95M
SectorFinancial ServicesFinancial Services
IndustryShell CompaniesShell Companies

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Drugs Made In America Acquisition II

DMII stock →

Drugs Made In America Acquisition II Corp. does not have significant operations.

Financial Services · Shell Companies

About EQV Ventures Acquisition II

EVAC stock →

EQV Ventures Acquisition Corp. II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

Financial Services · Shell Companies

DMII vs EVAC FAQ

Which is bigger, Drugs Made In America Acquisition II or EQV Ventures Acquisition II?

Drugs Made In America Acquisition II (DMII) is larger, with a market capitalization of $649.10M compared with $602.60M for EQV Ventures Acquisition II (EVAC).

Which has the lower P/E ratio, DMII or EVAC?

DMII has the lower trailing P/E at 34.0, versus 34.4 for EVAC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Drugs Made In America Acquisition II and EQV Ventures Acquisition II in the same industry?

Yes. Both are classified in the Shell Companies industry within the Financial Services sector.

More comparisons